Novartis AG/Fr. NOVN
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Novartis AG
Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel, Switzerland. It operates primarily in the healthcare industry, focusing on the research, development, and manufacturing of a wide range of prescription medications targeting oncology, immunology, neuroscience, and cardiovascular diseases. Key products include Cosentyx (for psoriasis and arthritis) and Entresto (for heart failure). Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has a significant geographic presence, with operations in over 100 countries. A key competitive strength of the company is its strong investment in research and development, which underpins its substantial portfolio of innovative therapies.
Ticker
Fr. NOVN
Sector
Primary listing
XSWX
Employees
75,267
Headquarters
Basel, Switzerland
Website
Novartis AG Metrics
BasicAdvanced
CHF 222bn
21.91
CHF 5.56
0.49
CHF 3.70
3.04%
Price and volume
Market cap
CHF 222bn
Beta
0.49
52-week high
CHF 131.00
52-week low
CHF 91.20
Average daily volume
2.7m
Dividend rate
CHF 3.70
Financial strength
Current ratio
0.848
Quick ratio
0.526
Long term debt to equity
100.47
Total debt to equity
120.734
Dividend payout ratio (TTM)
64.15%
Interest coverage (TTM)
15.14%
Profitability
EBITDA (TTM)
18,239.952
Gross margin (TTM)
75.55%
Net profit margin (TTM)
23.92%
Operating margin (TTM)
32.56%
Effective tax rate (TTM)
14.38%
Revenue per employee (TTM)
CHF 596,800
Management effectiveness
Return on assets (TTM)
10.54%
Return on equity (TTM)
34.93%
Valuation
Price to earnings (TTM)
21.908
Price to revenue (TTM)
5.201
Price to book
6.02
Price to tangible book (TTM)
-8.13
Price to free cash flow (TTM)
18.249
Free cash flow yield (TTM)
5.48%
Free cash flow per share (TTM)
6.669
Dividend yield (TTM)
3.04%
Forward dividend yield
3.04%
Growth
Revenue change (TTM)
6.31%
Earnings per share change (TTM)
9.48%
3-year revenue growth (CAGR)
10.71%
10-year revenue growth (CAGR)
1.25%
3-year earnings per share growth (CAGR)
29.06%
10-year earnings per share growth (CAGR)
9.55%
3-year dividend per share growth (CAGR)
10.48%
10-year dividend per share growth (CAGR)
5.64%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs